Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Terplan, Mishka ^a   Lui, S ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

*Pregnant women psychology ; *Psychotherapy; Patient dropouts statistics numerical data ; Pregnancy complications psychology; *therapy ; Pregnancy outcome; Randomized controlled trials as topic; Reinforcement (psychology)

Indexed keywords

ILLICIT DRUG;

CLINICAL TRIAL; DRUG WITHDRAWAL; HEALTH PROGRAM; HUMAN; OUTPATIENT; PREGNANCY; PREGNANT WOMAN; PSYCHOTHERAPY; REVIEW; SYSTEMATIC REVIEW;

EID: 44949229231     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006037.pub2     Document Type: Review

References (71)

1. Carroll 1995 {published data only} *Carrol M, Chang G, Behr H, Clinton B, Kosten T. Improving Tratment Outcome in Pregnant, MEthadone-Maintained WOmen. American Journal on Addictions 1995;4(1):56-9.
2. Elk 1998 {published data only} *Elk R, Mangus L, Rhoades H, Andres R, Grabowski J. Cessation of cocaine use during pregnancy: effects of contingency management interventions on maintaining abstinence and complying with prenatal care. Addictive Behaviors 1998;23(1):57- 64.
3. Haug 2004 {published data only} *Haug N, Svikis D, DiClemente C. Motivational enhancement therapy for nicotine dependence in methadone- maintained pregnant women. Psychology of Addictive Behaviors 2004;18(3):289-92.
4. Jones 2000 {published data only} *Jones HE, Stitzer M, Svikis D. Improving treatment outcomes for pregnant drug-dependent women using low-magnitude voucher incentives. Addictive Behaviors 2000;25(2):263-7.
5. Jones 2001 {published data only} *Jones HE, Haug N, Silverman K, Stitzer M, Svikis D. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug and Alcohol Dependence 2001;61(3):297-306.
6. Mullins 2004 {published data only} *Mullins SM, Suarez M, Ondersman SJ, Page MC. The impact of motivational interviewing on substance abuse treatment retention: A randomized control trial of women involved with child welfare. Journal of Substance Abuse Treatment 2004;27(1):51-8.
7. O'Neill 1996 {published data only} *O'Neill K, Baker A, Cooke M, Collins E, Heather N, Wodak A. Evaluation of a cognitive-behavioural intervention for pregnant injecting drug users at risk of HIV infection. Addiction 1996;91(8):1115-25.
8. Silverman 2001 {published data only} *Silverman K, Svikis D, Eobles E, Stitzer M, Bigelow GE. A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes. Experimental and clinical psychopharmacology 2001;9(1):14-23.
9. Svikis 1997 {published data only} *Svikis D, Lee JH, Haug N, Stitzer M. Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women. Drug and Alcohol Dependence 1997;48(1):33-41.
10. Amato 2006 Amato L, Minozzi S, Davoli M, Vecchi S, Ferri M, Mayet S. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database of Systematic Reviews 2006, Issue 3.Art. No.: CD005031. DOI:10.1002/14651858.CD005031.
11. Ashley 2003 Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: A review. American Journal of Drug and Alcohol Abuse 2003;29(1):19-53.
12. Bolnick 2003 Bolnick JM, Rayburn WF. Substance use disorders in women: Special considerations during pregnancy. Obstetrics and Gynecology Clinics of North America 2003;30(3):545-58.
13. Brady 1993 Brady KT, Grice DE, Dustan L, Malcom R, Killeen T. Characteristics of pregnant cocaine abusers. NIDA Research Monograph 1993;132:114.
14. Chang 1992 Chang G, Carroll KM, Behr HM, Kosten TR. Improving treatment outcome in pregnant opiate dependent women. Journal of Substance Abuse Treatment 1992;9:327-30.
15. Chang 2005 Chang G, McNamara TK, Orav EJ, Koby D, Ludman B, Haug LW. Brief intervention for prenatal alcohol use: a randomized trial. Obstetrics and Gynecology 2005;105(5):991-8.
16. Chazotte 1995 Chazotte C, Youchah J, Freda MC. Cocaine use during pregnancy and lowbirth weight: The impact of prenatal care and drug treatment. Seminars in Perinatology 1995;19(4):293-200. [MEDLINE: 22].
17. Clark 2001 Clark KA, Dee DL, Bale PL, Martin SL. Treatment compliance among prenatal care patients with substance abuse problems. American Journal of Drug and Alcohol Abuse 2001;27(1):121-36.
18. Daley 2005 Daley M, Shepard D, Maynard DB. Changes in quality of life for pregnant women in substance user treatment: Developing a quality of life index for the addictions. Substance Use and Misuse 2005;40(3):375-94.
19. Day 2003 Day E, Porter L, Clarke A, Allen D, Moselhy H, Copello A. Drug misuse in pregnancy: The impact of a specialist treatment service. Psychiatric Bulletin 2003;27(3):99-101.
20. Drozdick 2002 Drozdick J, Berghella V, Hill M, Kaltenbach K. Methadone trough levels in pregnancy. American Journal of Obstetrics and Gynecology 2002;187(5):1184-8.
21. Egelko 1998 Egelko S, Galanter M, Dermatis H, DeMaio C. Evaluation of a multisystemsmodel for treating perinantal cocaine addiction. Journal of Substance Abuse Treatment 1998;15(3):251-9.
22. Elk 1997 *Elk R, Mangus LG, LaSoya RJ, Rhoades HM, Andres RL, Grabowski J. Behavioral Interventions: Effectuve and adaptable for the treatment of pregnant cocaine-dependent women. Journal of Drug Issues 1997;27(3):625-58.
23. Elk 1995 Elk R, Schmitz J, Spiga R, Rhoades H, Andres R, Grabowski J. Behavioral treatment of cocaine-dependent pregnant women and TB-exposed patients. Addictive Behaviors 1995;20(4):533-42.
24. Finnegan 2005 Finnegan LP, Amass L, Jones HE, Kaltenbach K. Addiction and Pregnancy. Heroin Addiction and Related Clinical Problems 2005;7(4):5-22.
25. Fischer 1999 *Fischer G, Jagsch R, Eder H, Gombas W, Etzersdorfer P, Schmidl-Mohl K, et al.Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction 1999;94(2): 231-9.
26. Funai 2003 Funai EF, White J, Lee MJ, Allen M, Kuczynski E. Compliance with prenatal care visits in substance abusers. Journal of Maternal-Fetal and Neonatal Medicine 2003;14(5):329-32.
27. Fundaro 2004 Fundaro C, Genovese O, Baldieri F, Miccinesi N. Long-term neurodevelopmental outcome of children exposed to illicit substances during pregnancy: The role of home environmental factors. Italian Journal of Pediatrics 2004;30(2):118-24.
28. Hulse 2002 Hulse G, O'Neil G. Using naltrexone implants in the management of the pregnant heroin user. Australian and New Zealand Journal of Obstetrics and Gynaecology 2002;42(5):569-73.
29. Jansson 2003 Jansson L, Svikis D, Beilenson P. Effectiveness of Child Case Management Services for Offspring of Drug- Dependent Women. Substance Use and Misuse 2003;38(14):1933-52.
30. Jones 2002 Jones HE, Svikis D, Tran G. Patient compliance and maternal/infant outcomes in pregnant drug-using women. Substance Use and Misuse 2002;37(11):1411-22.
31. Jones 2004 Jones HE, Svikis D, Rosado J, Tuten M, Kulstad JL. What if they do not want treatment?: Lessons learned from intervention studies of non-treatment-seeking, drug-using pregnant women. American Journal on Addictions 2004;13(4):342-57.
32. Kastner 2002 Kastner R, Hartl K, Lieber A, Hahlweg BC, Knobbe A, Grubert T, et al.Opiate addiction during pregnancy: Results of a psychosomatic treatment strategy with replacement therapy. Geburtshilfe und Frauenheilkunde 2002;32(1):32-6.
33. Kukko 1999 Kukko H, Halmesmaki E. Prenatal care and counseling of female drug abusers: effcets on drug abuse and perinatal outcomes. Acta Obstetricia et Gynecologica Scandinavica 1999;78:22-6.
34. Nishimoto 2001 Nishimoto RH, Roberts AC. Coercion and drug treatment for postpartum women. American Journal of Drug and Alcohol Abuse 2001;27(1):161-81.
35. Ondersman 2005 Ondersman SJ, Chase SK, Svikis D, Schuster CR. Computer-based brief motivational intervention for perinatal drug use. Journal of Substance Abuse Treatment 2005;28(4):305-12.
36. Rayburn 2004 Rayburn WF, Bogenschutz MP. Pharmacotherapy for pregnant women with addictions. American Journal of Obstetrics and Gynecology 2004;191(6):1885-97.
37. Seracini 1997 Seracini AM, Nunes E, Tross S, Spano C. Achieving cocaine abstinence in preinatal cocaine-dependent women: A contingency management approach. Problems of Drug Dependence 1996: Proceedings of the 58th Annual Scientific Meeting. Washington DC: NIH 97-4236, 1996:261.
38. Shieh 2002 Shieh C, Kravitz M. Maternal-fetal attachment in pregnant women who use illicit drugs. Journal of Obstetric, Gynecologic and Neonatal Nursing 2002;31(2):156-64.
39. Svikis 1998 Svikis D, McCaul M, Feng T, Stuart M, Fox M, Stokes E. Drug Dependence During Pregnancy: Effect of an on-site support group. Journal of Reproductive Medicine 1998;49:799-805.
40. Sweeney 2000 Sweeney PJ, Schwartz RM, Mattis NG, Vohr B. The effect of integrating substance abuse treatment with prenatal care on birth outcome. Journal of Perinatology 2000;4:219-24.
41. Weisdorf 1999 Weisdorf T, Parran TV, Graam A, Snyder C. Comparison of pregnancy-specific interventions to a traditional treatment program for cocaine-addicted pregnant women. Journal of Substance Abuse Treatment 1999;16(1):39-45.
42. Wexler 1998 Wexler HK, Cuadrado M, Stevens SJ. Residential Treatment for Women: Behavioral and Psychological Outcomes. In: StevensS, WexlerHK editor(s). Women and Substance Abuse. NY: The Hawthorne Medical Press, 1998:213-33.
43. Winhusen 2003 Winhusen TM, Kropp F. Psychosocial treatments for women with substance use disorders. Obstetrics and Gynecology Clinics of North America 2003;30(3):483-99.
44. Zlotnick 1996 Zlotnick C, Franchio K, Claire N, Cox K, John M. The impact of outpatient drug services on abstinence among pregnant and parenting women. Journal of Substance Abuse Treatment 1996;13(3):195-202.
45. Armstrong 2003 Armstrong MA, Gonzales Osejo V, Lieberman L, Carpenter DM, Pantoja PM, Escobar GJ. Perinatal Substance Abuse Intervention in Obstetric Clinics Decreases Adverse Neonatal Outcomes. Journal of Perinatology 2003;23:3-9.
46. Boyd 1999 Boyd SC. Mothers and illicit drugs: transcending the myths. Toronto: University of Toronto Press, 1999.
47. Brunader 1991 Brunader RE, Brunader JA, Kugler JP. Prevalence of cocaine and marijuana use among pregnant women in a military health care setting. Journal of the American Board of Family Practice 1991;4(6):395-8.
48. Dakof 2003 Dakof GA, Quille TJ, Tejeda MJ, Alberga LR, Bandstra E, Szapocznik J. Enrolling and retaining mothers of substance-exposed infants in drug abuse treatment. Journal of Consilting and Clinical Psychology 2003;71(4):764-72.
49. Daley 1998 Daley M, Argeriouu M, McCarty D. Substance abuse treatment for pregnant women: A wondow of oppotunity?. Addictive Behaviors 1998;23(2):239-49.
50. DiClemente 1998 DiClemente CC, Prochaska JO. Towards a comprehensive, transtheoretical model of change: Stages of change and addictive behaviours. In: MillerWR, HeatherN editor(s). Treating Addictive Behaviours. 2. New York: Plenum Press, 1998:3-24.
51. Frank 2001 Frank DA, Augustyn M, Knight WG, Pell T, Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure. Journal of the American Medical Association 20011;285(12):1613-25.
52. George 1991 George SK, Price J, Hauth JC, Barnette DM, Preston P. Drug abuse screening of childbearing-age women in ALabama public health clinics. American Journal of Obstetrics and Gynecology 1991;165(4):924-7.
53. Grella 2000 Grella CE, Joshi V, Hser Y. Program variation in treatment outcomes among women in residential drug treatment. Evaluation Reviewss 2000;24:364-83.
54. Grimes 2005 Grimes DA, Schulz KF. Surrogate end points in clinical research: hazardous to your health. Obstetrics and Gynecology 2005;105(5):1114-8.
55. Hettema 2005 Hettema J, Steele J, Miller WR. Motivational Interviewing. Annual Review of Clinical Psychology 2005;1:91-111.
56. Higgins 1991 Higgins ST, Delaney DD, Budney EJ, Bickel WK, Hughes JR, Foerg F, et al.A behavioral approach to achieving intial cocaine abstinence. American Journal of Psychiatry 1991;148(9):1218-24.
57. Higgins 2007 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library 2007, issue 3.
58. Howell 2000 Howell EM, Heiser N, Cherlow A, Mason M, Ewell D, Potwein S. Identifying pregnant substance abusers and studying their treatment using birth certificates, Medicaid claims, and state substance abuse treatment data. NIDA Research Monograph 2000;1:225-41.
59. Hser 1998 Hser Y, Maglione M, Polinsky ML, Anglin MD. Predicting drug treatment entry among treatment-seeking individuals. Journal of Substance Abuse Treatment 1998;15:213-20.
60. Hubbard 1989 Hubbard RL, Mardsen ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug Abuse Treatment: A national study of effectiveness. Chapel Hill: University of North Carolina Press, 1989.
61. Ludlow 2004 Ludlow, Joanne P, Sharon F Evans, Gary Hulse. Obstetrical and perintal outcomes in pregnancies associated with illicit substance abuse. Australian and New Zealand Journal of Obstetrics and Gynaecology 2004;44:302-6.
62. McCaul 1996 McCaul ME, Svikis DS. Service Utilization measures in drug treatment research. In: RahdertE editor(s). Treatment for drug exposed women and their children: Advances in research methodology. Washington DC: U.S. Government Printing Office, 1996:225-41.
63. Miller 2003 Miller WR, Yahne CE, Tonigan JS. Motivational Interviewing in Drug Abuse Services: A Randomized Trial. Journal of Consulting and CLinical Psychology 2003;71(4):754-63.
64. Murphy 1999 Murphy S, Rosennbaum M. Pregnant women on drugs: combating stereotypes and stigma. New Brunswick: Rutgers University Press, 1999.
65. Rollnick 1995 Rollnick S, Miller WR. What is Moticational Interviewing?. Behavioural and Cognitive Psychotherapy 1995;23:325-34.
66. Schulz 1995 Schulz, KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
67. Signorini 1993 Signorini SF, Leung O, Simes RJ, Beller E, Gebski VJ, Callaghan T. Dynamic balanced randomization for clinical trials. Statistics in Medicine 1993;12:2343-50.
68. Singer 2004 Singer LT, Minnes S, Short E, Arendt R, Farkas K, Lewis B, et al.Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA 2004;291(20):2448-56.
69. Sitzer 2006 Sitzer M, Nancy P. Contingency Management for Treatment of Substance Abuse. Annual Revew of Clinical Psychology 2006;2:411-34.
70. Skinner 1947 Skinner BF. Superstition in the Pidgeon. Journal of Experimental Psychology 1947;38:168-72.
71. Thorndike 1898 Thorndike EL. Animal intelligence: An experimental study of the associative processes in animals. Psychological Review Monograph Supplement 1898;2(4):109.